1832 Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-545,500
Closed -$102M 957
2022
Q3
$102M Buy
545,500
+476,200
+687% +$100M 0.19% 106
2022
Q2
$11.3M Sell
69,300
-373,200
-84% -$59M 0.02% 351
2022
Q1
$82.2M Sell
442,500
-228,700
-34% -$43.4M 0.12% 152
2021
Q4
$174M Sell
671,200
-58,800
-8% -$15.8M 0.31% 84
2021
Q3
$206M Hold
730,000
0.39% 75
2021
Q2
$146M Hold
730,000
0.28% 97
2021
Q1
$136M Hold
730,000
0.29% 90
2020
Q4
$136M Buy
730,000
+3,400
+0.5% +$619K 0.32% 82
2020
Q3
$108M Hold
726,600
0.28% 94
2020
Q2
$85.1M Sell
726,600
-1,800
-0.2% -$212K 0.26% 105
2020
Q1
$68.4M Hold
728,400
0.25% 94
2019
Q4
$65.9M Sell
728,400
-91,200
-11% -$7.66M 0.2% 104
2019
Q3
$61.4M Buy
819,600
+139,100
+20% +$12.2M 0.2% 107
2019
Q2
$55.8M Buy
+680,500
New +$46.4M 0.18% 116

Other funds holding RGEN

1832 Asset Management's RGEN Position: Q4 2022 in Review

1832 Asset Management sold out of Repligen (RGEN) in Q4 2022, closing a stake of 545,500 shares — an estimated $102M sold.

1832 Asset Management first reported a position in RGEN in Q2 2019 and held it in 14 quarters. The position peaked at $206M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • 1832 Asset Management reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • 1832 Asset Management sold 545,500 Repligen shares in Q4 2022, an estimated $102M.
  • 1832 Asset Management first reported a position in Repligen in Q2 2019 and held it in 14 quarters.
  • 1832 Asset Management's Repligen position peaked at $206M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on 1832 Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.